Health and Family Welfare Government Departments Closing in 9 days TDR #57164409

Tender For T.E.NO.GMSCL/D-798/RC/2026-27 TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (85 ITEMS)

Issued by Government Departments · Gandhinagar, Gujarat
Tender Value
Ref. Documents
Estimated cost
Bid Submission
08 Sep 2026
9 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
17700
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Gandhinagar → Gujarat
EMD Exemption
Not Available
Quantity
Not Available

Project Description

T.E.NO.GMSCL/D-798/RC/2026-27 TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (85 ITEMS)- amiodarone tablet 200 mg, folic acid and ferrous sulphate tablet (small), glipizide tablets 5 mg, isosorbide mononitrate tablets 10 mg, methyldopa tablets 250 mg, methylergometrine tablet 0.125 mg, metronidazole tablet 200 mg, tablet paracetamol 500 mg, tablet pyridostigmine 60 mg, vitamin a capsules 2,00,000 iu, levocetirizine tablets 5 mg, tablet nifedipine sustained release 20 mg, tablet paracetamol 650 mg, tablet lamotrigine 50 mg, tablet disulfiram 250 mg, tablet voglibose 0.3 mg, tablet gefitinib 250 mg, folic acid and ferrous sulphate tablets (large) (red colour), iron and folic acid tablet blue (large)-wifs, tablet ferrous sulphate 200 mg (elemental 60 mg), tablet terbinafine 250 mg, tablet ivermectin 12 mg, tablet nicorandil 10 mg, diltiazem modified release tablet 90 mg, labetalol tablet 100 mg, tablet trimethoprim and sulphamethoxazole 160 mg and 800 mg, tablet warfarin sodium 1 mg, tablet acyclovir 800 mg, tablet carvedilol 6.25 mg, prednisolone tablet 10 mg, tablet finasteride 1 mg, tablet posaconazole 100 mg, artesunate, pyrimethamine and sulphadoxine tablet ( 100 mg plus 37.5 mg plus 750 mg) (5 to 8 years), atazanavir 300 mg and ritonavir 100 mg tablets, amikacin sulphate injection 500 mg (for im/iv use), benzyl penicillin injection 500000 i.u., injection cefazoline sodium 500 mg for im/iv /infusion use, cefotaxime for injection 250 mg (for im/iv use), ceftriaxone for injection 500 mg (deep im/slow iv infusion), ciprofloxacin injection 2 mg/ml (iv infusion), dextrose injection 10percentage w/v (for i.v.infusion), dextrose injection 5percentage w/v (for i.v.infusion), injection fluphenazine decanoate 25 mg/ml, injection ketamine hcl 50 mg, (10 ml vial) (deep im/slow iv use), lignocaine hcl 20 mg and adrenaline bitartrate 0.01 mg injection (30 ml vial), lignocaine hydrochloride injection 2percentage w/v, (30 ml vial), metronidazole injection 5 mg/ml (100 ml ffs bottle) (i.v.infusion), multiple electrolyte and dextrose injection type 1 (paediatric) (multiple electrolyte p), ofloxacin injection 2 mg/ml (for iv infusion), injection lorazepam 2 mg/ml, ondansetron injection 2 mg/ml, 4 ml oule, iohexol injection (50 ml bottle/vial) (for i.v.use), tramadol injection 50 mg/ml, (2 ml oule), insulin (human) injection 40 i.u. / ml 50:50, injection cisplatin 10 mg (intravenous infusion), 10 ml vial, injection cisplatin 50 mg (intravenous infusion), hydroxy ethyl starch 6percentagew/v (intravenous infusion), phytomenadione (vitamin k1) injection 1 mg/0.5 ml (0.5 ml oule), linezolid infusion 200 mg/100 ml, (100 ml bottle), docetaxel 120 mg injection, epirubicin injection 50 mg, octreotide acetate injection 100 mcg, injection recombinant insulin glargine (100 iu/ml), lyophilized alteplase powder injection 20 mg, lyophilized alteplase powder injection 50 mg, injection risperidone 37.5 mg (long acting injection for im use), clindamycin injection 600 mg (4 ml ), terlipressin injection (100 mcg/ml), 10 ml each vial/ oule, injection betamethasone 4 mg/ml (1 ml ), injection risperidone 50 mg, amoxycillin oral suspension 125 mg/5 ml, glutaral disinfectant solution (glutaral dehyde solution 2percentage), glycerine 1 kg bottle, povidone iodine solution 5percentage w/v (1 litre), sodium valproate oral solution 200 mg/5 ml, zinc gluconate syrup 20 mg/5 ml, (60 ml bottle), lignocaine hydrochloride jelly 5 percentage w/w, 30 gm tube, povidone iodine solution 10percentage w/v, calcium and vitamin d 3 suspension (250 mg + 125 iu), budesonide inhaler 100 mcg/dose, tropicamide 0.8percentage + phenylephrine 5percentage eye drops, 5 ml vial, bromfenac 0.09percentage eye drops, 5 ml vial, sodium chloride eye ointment 6percentage w/w, 3 gm tube, moxifloxacin eye ointment 0.5percentage, 5 gm tube, formoterol 6 mcg+ budenoside 200 mcg inhaler.

BOQ

Sl. No. Item Name
1amiodarone tablet 200 mg
2Folic Acid and Ferrous Sulphate Tablet (Small)
3Glipizide Tablets 5 mg
4Isosorbide Mononitrate Tablets 10 mg
5Methyldopa Tablets 250 mg
6Methylergometrine Tablet 0.125 mg
7Metronidazole Tablet 200 mg
8Tablet Paracetamol 500 mg
9Tablet Pyridostigmine 60 mg
10Vitamin A Capsules 2,00,000 IU
11Levocetirizine Tablets 5 mg
12Tablet Nifedipine sustained Release 20 mg
13Tablet Paracetamol 650 mg
14Tablet Lamotrigine 50 mg
15Tablet Disulfiram 250 mg
16Tablet Voglibose 0.3 mg
17Tablet Gefitinib 250 mg
18Folic Acid and Ferrous Sulphate Tablets (Large) (Red Colour)
19Iron and Folic acid tablet Blue (Large)-WIFS
20Tablet Ferrous Sulphate 200 mg (elemental 60 mg)
21Tablet Terbinafine 250 mg
22Tablet Ivermectin 12 mg
23Tablet Nicorandil 10 mg
24Diltiazem modified release Tablet 90 mg
25Labetalol Tablet 100 mg
26Tablet Trimethoprim and Sulphamethoxazole 160 mg and 800 mg
27Tablet Warfarin Sodium 1 mg
28Tablet Acyclovir 800 mg
29Tablet Carvedilol 6.25 mg
30Prednisolone Tablet 10 mg
31Tablet Finasteride 1 mg
32Tablet Posaconazole 100 mg
33Artesunate, Pyrimethamine and sulphadoxine Tablet ( 100 mg plus 37.5 mg plus 750 mg) (5 to 8 years)
34Atazanavir 300 mg and Ritonavir 100 mg tablets
35Amikacin Sulphate Injection 500 mg (For IM/IV Use)
36Benzyl Penicillin Injection 500000 I.U.
37Injection Cefazoline Sodium 500 mg For IM/IV /Infusion use
38Cefotaxime for Injection 250 mg (for IM/IV use)
39Ceftriaxone for Injection 500 mg (Deep IM/Slow IV Infusion)
40Ciprofloxacin Injection 2 mg/ml (IV Infusion)
41Dextrose Injection 10Percentage w/v (For I.V.Infusion)
42Dextrose Injection 5Percentage w/v (For I.V.Infusion)
43Injection Fluphenazine Decanoate 25 mg/ml
44Injection Ketamine HCL 50 mg, (10 ml vial) (Deep IM/slow IV use)
45Lignocaine HCL 20 mg and Adrenaline Bitartrate 0.01 mg Injection (30 ml vial)
46Lignocaine Hydrochloride Injection 2Percentage W/V, (30 ml Vial)
47Metronidazole Injection 5 mg/ml (100 ml FFS bottle) (I.V.Infusion)
48Multiple Electrolyte and Dextrose Injection type 1 (Paediatric) (Multiple Electrolyte P)
49Ofloxacin Injection 2 mg/ml (For IV infusion)
50Injection Lorazepam 2 mg/ml
51Ondansetron Injection 2 mg/ml, 4 ml Ampoule
52Iohexol Injection (50 ml Bottle/vial) (For I.V.use)
53Tramadol Injection 50 mg/ml, (2 ml Ampoule)
54Insulin (Human) Injection 40 I.U. / ml 50:50
55Injection Cisplatin 10 mg (Intravenous Infusion), 10 ml vial
56Injection Cisplatin 50 mg (Intravenous Infusion)
57Hydroxy ethyl Starch 6PercentageW/V (Intravenous Infusion)
58Phytomenadione (Vitamin K1) Injection 1 mg/0.5 ml (0.5 ml Ampoule)
59Linezolid infusion 200 mg/100 ml, (100 ml Bottle)
60Docetaxel 120 mg Injection
61Epirubicin injection 50 mg
62Octreotide Acetate Injection 100 mcg
63Injection Recombinant Insulin Glargine (100 IU/ml)
64Lyophilized Alteplase Powder Injection 20 mg
65Lyophilized Alteplase Powder Injection 50 mg
66Injection Risperidone 37.5 mg (Long acting injection For IM use)
67Clindamycin Injection 600 mg (4 ml Amp)
68Terlipressin Injection (100 mcg/ml), 10 ml Each vial/ampoule
69Injection Betamethasone 4 mg/ml (1 ml Amp)
70Injection Risperidone 50 mg
71Amoxycillin oral suspension 125 mg/5 ml
72Glutaral Disinfectant Solution (Glutaral dehyde Solution 2Percentage)
73Glycerine 1 kg Bottle
74Povidone Iodine Solution 5Percentage W/V (1 Litre)
75Sodium Valproate Oral Solution 200 mg/5 ml
76Zinc Gluconate Syrup 20 mg/5 ml, (60 ml Bottle)
77Lignocaine Hydrochloride Jelly 5 Percentage w/w, 30 gm Tube
78Povidone Iodine Solution 10Percentage w/v
79Calcium and Vitamin D 3 Suspension (250 mg + 125 IU)
80Budesonide Inhaler 100 mcg/dose
81Tropicamide 0.8Percentage + Phenylephrine 5Percentage Eye Drops, 5 ml Vial
82Bromfenac 0.09Percentage Eye Drops, 5 ml Vial
83Sodium Chloride Eye Ointment 6Percentage w/w, 3 gm Tube
84Moxifloxacin Eye Ointment 0.5Percentage, 5 gm tube
85Formoterol 6 mcg+ Budenoside 200 mcg inhaler.

AI Tender Summary

OUR REF NO 57164409
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 08-09-2026
Authority
Authority Name Gujarat Medical Services Corporation Limited
Work Description T.E.NO.GMSCL/D-798/RC/2026-27 TABLET CAPSULE,INJECTION,MISSELENEOUS ITEMS (85 ITEMS)- amiodarone tablet 200 mg, folic acid and ferrous sulphate tablet (small), glipizide tablets 5 mg, isosorbide mononitrate tablets 10 mg, methyldopa tablets 250 mg, methylergometrine tablet 0.125 mg, metronidazole tablet 200 mg, tablet paracetamol 500 mg, tablet pyridostigmine 60 mg, vitamin a capsules 2,00,000 iu, levocetirizine tablets 5 mg, tablet nifedipine sustained release 20 mg, tablet paracetamol 650 mg, tablet lamotrigine 50 mg, tablet disulfiram 250 mg, tablet voglibose 0.3 mg, tablet gefitinib 250 mg, folic acid and ferrous sulphate tablets (large) (red colour), iron and folic acid tablet blue (large)-wifs, tablet ferrous sulphate 200 mg (elemental 60 mg), tablet terbinafine 250 mg, tablet ivermectin 12 mg, tablet nicorandil 10 mg, diltiazem modified release tablet 90 mg, labetalol tablet 100 mg, tablet trimethoprim and sulphamethoxazole 160 mg and 800 mg, tablet warfarin sodium 1 mg, tablet acyclovir 800 mg, tablet carvedilol 6.25 mg, prednisolone tablet 10 mg, tablet finasteride 1 mg, tablet posaconazole 100 mg, artesunate, pyrimethamine and sulphadoxine tablet ( 100 mg plus 37.5 mg plus 750 mg) (5 to 8 years), atazanavir 300 mg and ritonavir 100 mg tablets, amikacin sulphate injection 500 mg (for im/iv use), benzyl penicillin injection 500000 i.u., injection cefazoline sodium 500 mg for im/iv /infusion use, cefotaxime for injection 250 mg (for im/iv use), ceftriaxone for injection 500 mg (deep im/slow iv infusion), ciprofloxacin injection 2 mg/ml (iv infusion), dextrose injection 10percentage w/v (for i.v.infusion), dextrose injection 5percentage w/v (for i.v.infusion), injection fluphenazine decanoate 25 mg/ml, injection ketamine hcl 50 mg, (10 ml vial) (deep im/slow iv use), lignocaine hcl 20 mg and adrenaline bitartrate 0.01 mg injection (30 ml vial), lignocaine hydrochloride injection 2percentage w/v, (30 ml vial), metronidazole injection 5 mg/ml (100 ml ffs bottle) (i.v.infusion), multiple electrolyte and dextrose injection type 1 (paediatric) (multiple electrolyte p), ofloxacin injection 2 mg/ml (for iv infusion), injection lorazepam 2 mg/ml, ondansetron injection 2 mg/ml, 4 ml oule, iohexol injection (50 ml bottle/vial) (for i.v.use), tramadol injection 50 mg/ml, (2 ml oule), insulin (human) injection 40 i.u. / ml 50:50, injection cisplatin 10 mg (intravenous infusion), 10 ml vial, injection cisplatin 50 mg (intravenous infusion), hydroxy ethyl starch 6percentagew/v (intravenous infusion), phytomenadione (vitamin k1) injection 1 mg/0.5 ml (0.5 ml oule), linezolid infusion 200 mg/100 ml, (100 ml bottle), docetaxel 120 mg injection, epirubicin injection 50 mg, octreotide acetate injection 100 mcg, injection recombinant insulin glargine (100 iu/ml), lyophilized alteplase powder injection 20 mg, lyophilized alteplase powder injection 50 mg, injection risperidone 37.5 mg (long acting injection for im use), clindamycin injection 600 mg (4 ml ), terlipressin injection (100 mcg/ml), 10 ml each vial/ oule, injection betamethasone 4 mg/ml (1 ml ), injection risperidone 50 mg, amoxycillin oral suspension 125 mg/5 ml, glutaral disinfectant solution (glutaral dehyde solution 2percentage), glycerine 1 kg bottle, povidone iodine solution 5percentage w/v (1 litre), sodium valproate oral solution 200 mg/5 ml, zinc gluconate syrup 20 mg/5 ml, (60 ml bottle), lignocaine hydrochloride jelly 5 percentage w/w, 30 gm tube, povidone iodine solution 10percentage w/v, calcium and vitamin d 3 suspension (250 mg + 125 iu), budesonide inhaler 100 mcg/dose, tropicamide 0.8percentage + phenylephrine 5percentage eye drops, 5 ml vial, bromfenac 0.09percentage eye drops, 5 ml vial, sodium chloride eye ointment 6percentage w/w, 3 gm tube, moxifloxacin eye ointment 0.5percentage, 5 gm tube, formoterol 6 mcg+ budenoside 200 mcg inhaler.
Basic Detail
Tender No T.E.NO.GMSCL/D-798/RC/2026-27
Bidding Type Tender
Location
City Gandhinagar
State Gujarat
Key Dates
Publish Date 24 Aug 2026
Submission Date 08 Sep 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee 17700
EMD Ref. Documents
Exemption Not Available
Document List
9f4b5a602d714fd4998352a0ea0a3a30.html
AgreementandBankGuarantee15.pdf
DebarmentPolicy19.pdf
GRlistofbank20261.pdf
RateContractTermsandCondition15.pdf
TenderDocumentD798.pdf
TenderNoticeD798.pdf
TenderScheduleD798.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Aug 24, 2026
11:30 IST

Tender Published

Tender notice published.

Completed
Sep 08, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 9 days

Tender Documents

Download All (ZIP) ↓
html

9f4b5a602d714fd4998352a0ea0a3a30.html

pdf

AgreementandBankGuarantee15.pdf

pdf

DebarmentPolicy19.pdf

pdf

GRlistofbank20261.pdf

pdf

RateContractTermsandCondition15.pdf

pdf

TenderDocumentD798.pdf

pdf

TenderNoticeD798.pdf

pdf

TenderScheduleD798.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders